Acquisition of SomaScan 7K and 11K Assay Kits

Awarded Limited / Sole Source Justification Posted

Solicitation number
JA-NIAID-25-2244738
Agency
Set-aside
No set-aside

Opportunity facts

Contract number
75N93025P00923 Federal contract award
Place of performance
Colorado 80301, United States

Notice details come from SAM.gov. Updated .

About this opportunity

The National Institute of Allergy and Infectious Diseases (NIAID) issued a Limited / Sole Source Justification Notice for the acquisition of 59 SomaScan 7K and 11K assay kits from SomaLogic Operating Co. to support the Center for Human Immunology (CHI) at NIH. The procurement, valued at over $1.5 million in dedicated equipment and research investment, focuses on highly specialized protein analysis kits capable of analyzing 11,000 proteins across various biological samples with high accuracy and minimal sample volume requirements. SomaLogic was determined to be the sole manufacturer capable of meeting the precise technical specifications for proteomic research, with a performance period spanning from March 31, 2025 to March 30, 2026. The acquisition will be conducted on a firm-fixed-price basis, following a Notice of Intent posted on SAM.gov that received two responses, with only SomaLogic deemed capable of satisfying the government's specific technical needs. This sole-source justification underscores the unique technological capabilities required for advancing clinical trials and longitudinal research studies in immunological research.

Notice text

See attached Justification and Approval.

Awarded contract 75N93025P00923 to unknown vendor for unknown amount on 2025-04-18.

Files

On GovTribe

Work this opportunity

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity

GovTribe for Federal Contractors